Anand; Neel K.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Anand; Neel K..The latest application filed is for "adenosine 2 receptor antagonists".

Company Profile

10.21.23

Anand; Neel K. - San Mateo CA
Anand; Neel K. - Burlingame CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Adenosine 2 Receptor Antagonists App 20220235056 - Anand; Neel K. ; et al.	2022-07-28
N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the .kappa. opioid receptor Grant 11,241,415 - Duarte , et al. February 8, 2	2022-02-08
Immunotherapeutic Tumor Treatment Method App 20210292425 - Kivimae; Saul ; et al.	2021-09-23
Kappa opioid agonists and uses thereof Grant 11,111,214 - Anand , et al. September 7, 2	2021-09-07
Immunotherapeutic Tumor Treatment Method App 20210130467 - Zalevsky; Jonathan ; et al.	2021-05-06
Multi-arm Polymer Conjugates Of Tlr Agonist Compounds And Related Immunotherapeutic Treatment Methods App 20210128737 - Ren; Zhongxu ; et al.	2021-05-06
Opioid agonists and uses thereof Grant 10,865,186 - Duarte , et al. December 15, 2	2020-12-15
Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine Grant 10,844,076 - Sharma , et al. November 24, 2	2020-11-24
Morphinan derivatives for the treatment of neuropathic pain Grant 10,766,864 - Anand , et al. Sep	2020-09-08
Kappa Opioid Agonists And Uses Thereof App 20190352291 - Anand; Neel K. ; et al.	2019-11-21
Oligomer-containing benzamide-based compounds Grant 10,434,181 - Cheng , et al. O	2019-10-08
Kappa opioid agonists and uses thereof Grant 10,407,416 - Anand , et al. Sept	2019-09-10
N-methyl-n-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide Derivatives Agonists For The Kappa Opioid Receptor App 20190269652 - Duarte; Franco J. ; et al.	2019-09-05
N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the kappa opioid receptor Grant 10,322,107 - Duarte , et al.	2019-06-18
Solid dosage formulations of substituted quinazoline receptor-type kinase modulators and methods of use thereof Grant 10,266,518 - Rice , et al.	2019-04-23
Derivatives Of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine App 20190071454 - Sharma; Pankaj ; et al.	2019-03-07
Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine Grant 10,189,859 - Sharma , et al. Ja	2019-01-29
Opioid Agonists And Uses Thereof App 20180362468 - Duarte; Franco J. ; et al.	2018-12-20
Opioid agonists and uses thereof Grant 10,081,602 - Duarte , et al. September 25, 2	2018-09-25
Morphinan Derivatives For The Treatment Of Neuropathic Pain App 20180127375 - Anand; Neel K. ; et al.	2018-05-10
Receptor-Type Kinase Modulators and Methods of Use App 20180118724 - Rice; Kenneth D. ; et al.	2018-05-03
Oligomer-containing benzamide-based compounds Grant 9,937,266 - Cheng , et al. April 10, 2	2018-04-10
Kappa Opioid Agonists And Uses Thereof App 20180016266 - Anand; Neel K. ; et al.	2018-01-18
N-methyl-n-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide Derivatives Agonists For The Kappa Opioid Receptor App 20170368029 - Duarte; Franco J. ; et al.	2017-12-28
Kappa opioid agonists and uses thereof Grant 9,815,824 - Anand , et al. November 14, 2	2017-11-14
Substituted quinazolines as receptor-type kinase inhibitors Grant 9,796,704 - Rice , et al. October 24, 2	2017-10-24
Opioid Agonists And Uses Thereof App 20170253565 - Duarte; Franco J. ; et al.	2017-09-07
Opioid agonists and uses thereof Grant 9,688,638 - Duarte , et al. June 27, 2	2017-06-27
Derivatives Of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine App 20170066782 - Sharma; Pankaj ; et al.	2017-03-09
Opioid Agonists And Uses Thereof App 20170022167 - Duarte; Franco J. ; et al.	2017-01-26
Oligomer-containing Benzamide-based Compounds App 20160339108 - Cheng; Lin ; et al.	2016-11-24
Oligomer-containing benzamide-based compounds Grant 9,375,486 - Cheng , et al. June 28, 2	2016-06-28
Processes for the preparation of substituted quinazolines Grant 9,359,332 - Rice , et al. June 7, 2	2016-06-07
Kappa Opioid Agonists And Uses Thereof App 20160145245 - Anand; Neel K. ; et al.	2016-05-26
Receptor-Type Kinase Modulators and Methods of Use App 20160129032 - Rice; Kenneth D. ; et al.	2016-05-12
Oligomer-Containing Benzamide-Based Compounds App 20150250894 - Cheng; Lin ; et al.	2015-09-10
Receptor-Type Kinase Modulators and Methods of Use App 20140155418 - Rice; Kenneth D. ; et al.	2014-06-05
Receptor-type kinase modulators and methods of use Grant 8,658,654 - Rice , et al. February 25, 2	2014-02-25
Kinase modulators and methods of use Grant 8,076,338 - Anand , et al. December 13, 2	2011-12-13
Receptor-type kinase modulators and methods of use App 20090318373 - Rice; Kenneth D. ; et al.	2009-12-24
Receptor-type kinase modulators and methods of use Grant 7,576,074 - Rice , et al. August 18, 2	2009-08-18
Kinase Modulators and Methods of Use App 20080076774 - Anand; Neel K. ; et al.	2008-03-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.